Top Markets
Coin of the day
CardioGenics Holdings Inc CardioGenics Holdings Inc

CardioGenics Holdings Inc

CGNH
Clasificación en acciones #41819
CardioGenics Holdings Inc. focuses on the creation and global distribution of... CardioGenics Holdings Inc. focuses on the creation and global distribution of diagnostic testing solutions within the in vitro diagnostics (IVD) sector, serving markets across the United States, Canada, Europe, and other international regions. A key offering is the QL Care Analyzer, an automated, self-contained, and portable point-of-care (POC) immunoassay device. This analyzer utilizes a unique, patented self-metering cartridge to perform immunoassay evaluations directly at the point of care. The company also provides a range of immunoassay panels specifically engineered to detect cardiac biomarkers in blood, which is vital for identifying heart attacks. Additionally, CardioGenics supplies paramagnetic beads, serving as crucial solid supports in heterogeneous immunoassay procedures for both clinical and research institutions. Established in 1997, the company was initially known as Jag Media Holdings, Inc. before officially changing its name to CardioGenics Holdings Inc. in 2009. Its corporate headquarters are situated in Mississauga, Canada.
Precio por acción
$0.0001
Última sincronización: 2026-08-11
Capitalización bursátil
$9.61K
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
CA
Comercio CardioGenics Holdings Inc (CGNH)

Categoría

Ratio P/B de CardioGenics Holdings Inc (CGNH)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de CardioGenics Holdings Inc, el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de CardioGenics Holdings Inc desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
4.0441 -
US
2.6166 -
US
- -
CN
28.7765 -
US
21.3575 -
US